Psychedelic psilocybin-assisted therapy reduces depressive symptoms in adults with cancer and depression

Psilocybin-assisted group therapy in patients with cancer diagnosed with a major depressive disorder was safe and feasible

Psilocybin analog leads to 79% of remission in mid-stage depression trial

Exploring the Impact of Psilocybin on the Immune System: Insights from a Controlled Study on Healthy Participants

Psilocybin-Assisted Therapy for Depression: A review and meta-Analysis finds psilocybin to have a significantly greater antidepressant effect compared to the placebo drug used

Psilocybin might be effective for treatment-resistant depression even with ongoing SSRI use, study suggests

Repeated low doses of psilocybin increase resilience to stress, lower compulsive actions, and strengthen cortical connections to the paraventricular thalamic nucleus in rats

Benefits of psychedelics in obsessive-compulsive disorder: LSD and psilocybin have strong potential for providing long-lasting relief of patients’ symptoms

Psychedelic mushrooms and quiet quitting: Psilocybin use tied to working fewer overtime hours

Naturalistic psilocybin use associated with persisting improvement in wellbeing